Where I see patients (4)
My reviews
Selected research
-
Noninvasive Markers of Hepatic Steatosis and Fibrosis Following Integrase Strand-Transfer Inhibitor Initiation in Women With HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
State-of-the-Art Review: Hepatitis C.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
Weight gain in infancy and metabolic dysfunction-associated steatotic liver disease (MASLD) in a prospective birth cohort of Latino children.
Maternal health, neonatology and perinatology
Clinical trials
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Prevalence of hepatic steatosis in PLWH will be reported as the number of participants with hepatic steatosis, defined by controlled attenuation parameter (CAP) ≥263 dB/m, over the total number of participants assessed.
Recruiting
4.9